AbbVie’s Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod zbecker Fri, 04/26/2024 – 11:33 More: AbbVie's Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod Source: fierce
read moreGilead writes $2.4B off Trodelvy as CEO underscores ‘time of focused execution’ aliu Fri, 04/26/2024 – 11:05 More: Gilead writes .4B off Trodelvy as CEO underscores ‘time of focused execution’ Source: fierce
read morePfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose kdunleavy Fri, 04/26/2024 – 10:21 More: Pfizer scores FDA nod for hemophilia B gene therapy, will charge .5M per dose Source: fierce
read moreGSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit fkansteiner Fri, 04/26/2024 – 10:07 More: GSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit Source: fierce
read moreAbbVie’s Rinvoq conquers Regeneron and Sanofi’s Dupixent in eczema trial—again kdunleavy Fri, 04/26/2024 – 07:42 More: AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again Source: fierce
read moreThe new method could help to prevent severe side effects caused by enantiomer drugs More: Scientists reveal new method that could reduce waste from drug manufacturing Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals